Global burden of disease of HIVassociated cryptococcal meningitis: an updated analysis, Lancet Infect Dis, vol.17, pp.873-81, 2017. ,
A prospective study of mortality from cryptococcal meningitis following treatment induction with 1200 mg oral fluconazole in, PLOS One, vol.9, p.110285, 2014. ,
Dose response effect of high-dose fluconazole for HIV-associated cryptococcal meningitis in southwestern Uganda, Clin Infect Dis, vol.47, pp.1556-61, 2008. ,
A prospective longitudinal study of the clinical outcomes from cryptococcal meningitis following treatment induction with 800 mg oral fluconazole in, PLOS One, vol.8, p.67311, 2013. ,
Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi, Clin Infect Dis, vol.50, pp.338-382, 2010. ,
,
, Advancing Cryptococcal Meningitis Treatment for Africa Trial Study Team. Antifungal combinations for treatment of cryptococcal meningitis in Africa, N Engl J Med, vol.378, pp.1004-1021, 2018.
Advancing Cryptococcal Meningitis Treatment for Africa Trial Team. Health care costs and deaths prevented by ACTA trial treatments for cryptococcal meningitis: a comparison between 5 induction strategies in sub Saharan Africa, Clin Infect Dis, 2019. ,
, Guidelines for the diagnosis, prevention, and management of cryptococcal disease in HIV-infected adults, adolescents and children, Geneva: World Health Organization. Licence: CC BY, 2018.
Common methodological flaws in economic evaluations, Med Care, vol.43, pp.5-14, 2005. ,
Cryptococcal meningitis treatment strategies in resource-limited settings: a cost-effectiveness analysis, PLOS Med, vol.9, p.1001316, 2012. ,
Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies, PLOS Med, vol.10, p.1001418, 2013. ,
Life expectancy among HIV-positive patients in Rwanda: a retrospective observational cohort study, Lancet Glob Health, vol.3, pp.169-77, 2015. ,
Leave no-one behind: Responding to new evidence and guidelines for the management of cryptococcal meningitis in low-and middle-income countries, Epub ahead of print, pp.30493-30499, 2018. ,
Johns Hopkins ABX guide: diagnosis and treatment of infectious diseases, 2012. ,
One-step continuous flow synthesis of antifungal WHO essential medicine flucytosine using fluorine, Org Process Res Dev, vol.21, pp.273-279, 2017. ,
Cost-effectiveness analysis in disease control priorities, Disease control priorities, vol.9, pp.147-56, 2018. ,
Determinants of mortality in a combined cohort of 501 patients with HIV-associated cryptococcal meningitis: implications for improving outcomes, Clin Infect Dis, vol.58, pp.736-781, 2014. ,